Technical Analysis for MTZPY - Mitsubishi Tanabe Pharma Corporation

Grade Last Price % Change Price Change
grade A 18.6 -0.13% -0.0250
MTZPY closed down 0.13 percent on Friday, May 15, 2020, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical MTZPY trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Cup with Handle Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish -0.13%
Cup with Handle Other -0.13%
Narrow Range Bar Range Contraction -0.13%
NR7 Range Contraction -0.13%
NR7-2 Range Contraction -0.13%
Upper Bollinger Band Walk Strength -0.13%
Older signals for MTZPY ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mitsubishi Tanabe Pharma Corporation manufactures and sells pharmaceuticals in Japan, Europe, North America, other Asian countries, and internationally. The company offers drugs for autoimmune, diabetes, kidney, central nervous system, and other disease treatment; and vaccines, as well as sells generic drugs and over-the-counter (OTC) products. It offers Remicade for treatment of rheumatoid arthritis (RA), Crohn's, Bechet's, psoriasis, ankylosing spondylitis, and ulcerative colitis diseases; Simponi for the treatment of RA; Kremezin for the treatment of chronic renal failure; and Tenelia for type II diabetes mellitus. The company also provides Ceredist for the treatment of spinocerebellar degeneration; Depas, an anti-anxiety agent; Lexapro, an anti-depressant agent; Imusera for multiple sclerosis; Radicut, a cerebral neuroprotectant; Talion for the treatment of allergic disorders; Maintate for the treatment of hypertension, angina pectoris, ventricular extrasystole, chronic heart failure, and atrial fibrillation; Urso that improves hepatic, biliary, and digestive functions; and Anplag, an anti-platelet agent. In addition, it offers TETRABIK, a vaccine for diphtheria, pertussis, tetanus, and poliomyelitis; Varicella vaccine for the prevention of chicken pox; Influenza vaccine; Mearubik, a vaccine for measles and rubella; and JEBIK V for the prevention of Japanese encephalitis. Further, the company provides OTC products, including agents for the treatment of skin conditions; tonic and nutritional supplements; herbal and digestive medicines; and oral agents for allergic rhinitis and recurrent vaginal candidiasis. Additionally, it provides information about pharmaceuticals; and invests in bio-ventures. The company has collaborations with Dyadic International, Inc.; Hitachi Ltd.; and HitGen Ltd. The company was founded in 1678 and is headquartered in Osaka, Japan. The company is a subsidiary of Mitsubishi Chemical Holdings Corporation.
Medicine Medical Specialties RTT Pharmaceuticals Drugs Pharmaceutical Industry In China Diabetes Medication Disease Multiple Sclerosis Hypertension Rheumatoid Arthritis Psoriasis Influenza Vaccines Allergic Rhinitis Atrial Fibrillation Angina Pectoris Chronic Heart Failure Janssen Biotech Chronic Renal Failure Pertussis Remicade Rhinitis Spondylitis Tnf Inhibitors Treatment Of Hypertension

Is MTZPY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 18.8
52 Week Low 10.59
Average Volume 33,187
200-Day Moving Average 15.5118
50-Day Moving Average 17.8651
20-Day Moving Average 18.4081
10-Day Moving Average 18.5215
Average True Range 0.2381
ADX 14.89
+DI 16.6212
-DI 20.9174
Chandelier Exit (Long, 3 ATRs ) 17.9357
Chandelier Exit (Short, 3 ATRs ) 18.7143
Upper Bollinger Band 18.6797
Lower Bollinger Band 18.1365
Percent B (%b) 0.85
BandWidth 2.9509
MACD Line 0.1874
MACD Signal Line 0.1930
MACD Histogram -0.0056
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.6900
Resistance 3 (R3) 18.6967 18.6733 18.6750
Resistance 2 (R2) 18.6733 18.6504 18.6700 18.6700
Resistance 1 (R1) 18.6367 18.6363 18.6250 18.6300 18.6650
Pivot Point 18.6133 18.6133 18.6075 18.6100 18.6133
Support 1 (S1) 18.5767 18.5904 18.5650 18.5700 18.5350
Support 2 (S2) 18.5533 18.5763 18.5500 18.5300
Support 3 (S3) 18.5167 18.5533 18.5250
Support 4 (S4) 18.5100